Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • Log out
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Evaluation of the Vitek 2 ID-GNB Assay for Identification of Members of the Family Enterobacteriaceae and Other Nonenteric Gram-Negative Bacilli and Comparison with the Vitek GNI+ Card

Caroline M. O'Hara, J. Michael Miller
Caroline M. O'Hara
Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cmo1@cdc.gov
J. Michael Miller
Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.41.5.2096-2101.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We evaluated the Vitek 2 ID-GNB identification card (bioMérieux, Inc., Durham, N.C.) for its ability to identify members of the family Enterobacteriaceae and other gram-negative bacilli that are isolated in clinical microbiology laboratories. Using 482 enteric stock cultures and 103 strains of oxidase-positive, gram-negative glucose-fermenting and nonfermenting bacilli that were maintained at −70°C and passaged three times before use, we inoculated cards according to the manufacturer's directions and processed them in a Vitek 2 instrument using version VT2-R02.03 software. All panel identifications were compared to reference identifications previously confirmed by conventional tube biochemical assays. At the end of the initial 3-h incubation period, the Vitek 2 instrument demonstrated an accuracy of 93.0% for the identification of enteric strains; 414 (85.9%) were correctly identified at probability levels ranging from excellent to good, and an additional 34 (7.1%) strains were correctly identified but at a low level of discrimination. Nineteen (3.9%) strains were unidentified, and 15 (3.1%) were misidentified. The 19 unidentified strains were scattered among 10 genera. Three of the 15 misidentified strains were lactose-positive Salmonella spp. and were identified as Escherichia coli; another was a lactose-positive, malonate-negative Salmonella enterica subsp. arizonae strain that was identified as E. coli. Of the 103 glucose-fermenting and nonfermenting nonenteric strains, 88 (85.4%) were correctly identified at probability levels ranging from excellent to good, and 10 (9.7%) were correctly identified, but at a low level of discrimination, for a total of 95.1% accuracy with this group. Two strains were unidentified and three were misidentified. The errors occurred for strains in three different genera. With the increased hands-off approach of the Vitek 2 instrument and accuracies of 93% for the identification of enteric organisms and 95.1% for the identification of nonenteric organisms with the ID-GNB card, use of this product presents an acceptable method for the identification of most gram-negative organisms commonly isolated in the clinical laboratory. A comparison of these results to those obtained by testing 454 of the same strains with the Vitek GNI+ card revealed no significant difference in the abilities of the two cards to identify these organisms accurately.

Because relatively few commercially available molecular methods for the identification of clinically significant gram-negative bacilli in the clinical laboratory exist today, the need for identification procedures that use more conventional processes remains. Some of these phenotypic identification procedures are based on colorimetric or pH-based changes and usually require 18 to 24 h to identify organisms. Some are based on changes in preformed enzymes, shortening to 2 to 4 h the time necessary to make an identification.

The newest instrument for bacterial identification and susceptibility testing is Vitek 2 from bioMérieux, Inc. (Durham, N.C.). This is a fully automated system designed to decrease the turnaround time for the identification of bacteria and determination of antimicrobial susceptibilities. The instrument also provides a more hands-off approach than the original Vitek instrument.

The Vitek 2 ID-GNB card is a 64-well card designed for the automated identification of most clinically significant fermenting and nonfermenting gram-negative bacilli.

Because no U.S. studies have evaluated this instrument with an extensive organism library, we tested the ability of the Vitek ID-GNB card and the Vitek 2 instrument to identify strains of the family Enterobacteriaceae as well as glucose-fermenting and -nonfermenting gram-negative bacilli.

(This paper was presented in part at the 102nd General Meeting of the American Society for Microbiology, Salt Lake City, Utah, 19 to 23 May 2002 [C. M. O'Hara and J. M. Miller, Abstr. 102nd Gen. Meet. Am. Soc. Microbiol., abstr. C14, p. 101, 2002].)

MATERIALS AND METHODS

Culture collection.A total of 482 biochemically typical and atypical isolates of the family Enterobacteriaceae from the stock culture collection of the Centers for Disease Control and Prevention (CDC) were taken from storage in defibrinated sheep blood at −70°C and passaged three times on tryptic soy agar with 5% sheep blood (TSA II; Becton Dickinson Biosciences, Inc., Sparks, Md.) before use. In addition, 103 biochemically typical and atypical nonenteric, glucose-fermenting and -nonfermenting gram-negative bacilli were taken from the CDC stock culture collection. Ten recently isolated Salmonella strains from hospitals in the Atlanta, Ga., area were obtained from the Georgia Central Public Health Laboratory and passaged a third time on 5% sheep blood agar before use. All incubations were performed at 35 ± 1°C, unless indicated otherwise. ID-GNB cards were inoculated according to the directions of the manufacturer and processed in the Vitek 2 instrument with software version VT2-R02.02 (8 June 2000). Final test results were available in approximately 3 h.

Media and biochemical tests.Biochemical tests for the identification of enteric organisms were performed with conventional media and by the methods described by Edwards and Ewing (1), with some modifications by Hickman and Farmer (4) and Farmer et al. (2). Biochemical tests for identification of nonenteric organisms were performed by the methods of Weyant et al. (10) and Schreckenberger (9). Commercial media were used whenever possible.

Vitek 2 system.The Vitek 2 system is a fully automated, continuous-access testing system that can accommodate 60 identification or susceptibility cards at one time in one module. Additional modules that extend the capacity in increments of 60 cards are available.

The inoculation of cards begins with the preparation of a standardized bacterial suspension in 0.45% saline equivalent to a McFarland 0.5 to 0.63 standard, the range indicated by the manufacturer. The suspensions are standardized in a Densi-Chek 2, which is first adjusted with a semisolid calibrator. The suspensions are then placed into the Smart Carrier boat on the Smart Carrier cassette. The boat and cassette each contain a memory chip with information for the suspensions in that load. If a susceptibility test is to be performed simultaneously with the identification, an additional blank tube with 0.45% saline is placed in alternating slots. The time between suspension preparation and card filling for 10 isolates is less than 20 min. Suspensions are prepared in groups of 12 or less.

The ID-GNB cards each have a bar-coded label that is scanned into the memory chip before the cards are loaded into the corresponding slot.

Once the Smart Carrier boat is loaded into the Vitek 2 instrument, the instrument automatically reads the information from the memory chip, makes the dilution that is necessary if a susceptibility test is to be included, fills the test cards, severs the filling straws from the cards, and incubates the cards for 3 h. When the process is complete, onboard software and automation move the cards to the discard area, analyze the data, and print the results.

ID-GNB card.The ID-GNB card is a 64-well card that contains 41 biochemical tests (13 more substrates than the number included on the GNI+ card) and two negative control wells. Of the 41 biochemical tests, 21 are with conventional substrates that include adonitol, l-arabinose, d-cellobiose, d-galacturonate, d-glucose, d-glucuronate, myo-inositol, d-maltose, d-mannitol, d-melibiose, palatinose, d-raffinose, l-rhamnose, saccharose, d-sorbitol, d-trehalose, lysine and ornithine decarboxylases, urease, malonate, and tryptophane deaminase. Twenty wells contain preformed enzymes. These include glucose-1-phosphate, 5-keto-d-gluconate, α-arabinosidase, α-galactosidase, α-glutamate, β-cellobiosidase, β-galactosidase, β-glucosidase, β-glucuronidase, β-mannosidase, β-N-acetyl-glucosaminidase, β-N-acetyl-galactosaminidase, β-xylosidase, Glu-Gly-Arg arylamidase, γ-glutamyl-transferase, l-lysine arylamidase, phosphatase, l-proline arylamidase, l-pyrrolidonyl arylamidase, and CBZ-arginine arylamidase. The remaining wells are empty. Differences in the substrates between this card and the GNI+ card can be seen by consulting the respective product inserts.

Occasionally, additional off-line same-day testing may be required to complete an identification. Those tests listed by the manufacturer for the completion of an identification were performed with CDC conventional biochemicals. These included tests for indole production, motility, oxidase, β-hemolysis, and determination of brown, orange, purple, red, or yellow pigments.

Taxonomy.Organism identifications were taken from the Vitek database, even though some taxonomic changes may have occurred since the database was compiled.

Classification of answers.Answers may be categorized into one of several confidence levels (excellent, very good, good, acceptable), all of which are an estimate of how closely a given profile corresponds to a particular taxon relative to all the other taxa in the database. The percentage of identification ranges from 99.9 to 80.0%. This value is extrapolated from the t index, which is an estimate of how closely the profile corresponds to the most typical set of reactions for each taxon and which is actually calculated from the algorithm. The value of the t index varies between 0 and 1 and is inversely proportional to the number of atypical tests. Thus, a confidence level of excellent is a combination of a percentage of identification of ≥99.9% and a t index of ≥0.75. A confidence level of acceptable combines a percentage of identification of ≥80.0% and a t index of ≥0. In the case of a low level of discrimination, supplementary tests are proposed.

RESULTS AND DISCUSSION

The 482 enteric strains tested in this study included 21 genera and 60 species (Table 1). They represented most major species of the family Enterobacteriaceae, and all were of human origin. Because the CDC is usually not given patient histories when isolates are submitted, it is not known if they were clinically relevant, but most of the sources would indicate that the possibility of clinical relevance might exist. At the end of the initial 3-h incubation period, 414 (85.9%) isolates were correctly identified at confidence levels ranging from excellent to good. Another 34 (7.1%) were correctly identified, but at a low level of discrimination. In the clinical setting, these results would have to be carefully evaluated to determine if they were correct. The Vitek 2 instrument could not identify 19 (3.9%) of the 482 isolates and gave an answer of “unidentified organism.” Fifteen (3.1%) strains were incorrectly identified (Table 2), although six were at least in the correct genus. Most of these incorrect identifications were at the low level of discrimination.

View this table:
  • View inline
  • View popup
TABLE 1.

Enteric strains tested with the ID-GNB card

View this table:
  • View inline
  • View popup
TABLE 2.

Enteric strains that were misidentified

Of special interest in Table 2 are the lactose-positive Salmonella strains, one of which was Salmonella enterica subsp. arizonae. All four of these isolates were identified as Escherichia coli at the very good probability level.

Table 3 shows the test results for 103 isolates of nonenteric gram-negative bacilli that were a mixture of glucose-fermenting and glucose-nonfermenting, oxidase-positive and oxidase-negative organisms. They include 21 genera and 30 species. At the end of the initial incubation period, 88 (85.4%) strains were correctly identified at probability levels ranging from excellent to good. Ten (9.7%) were correctly identified, but at a low level of probability, and three (2.9%) were misidentified. The latter three included one isolate each of Aeromonas sobria, Brevundimonas vesicularis, and Empedobacter brevis. Two (1.9%) strains were not identified.

View this table:
  • View inline
  • View popup
TABLE 3.

Nonenteric strains tested with the ID-GNB card

Table 4 presents a comparison of the results of this study and those of the four other studies of the Vitek 2 instrument that have been published. There is no significant difference in the results obtained in this study compared with those obtained by Funke et al. (3) or Jossart and Courcol (5), although the smaller studies of Joyanes et al. (6), Ling et al. (7), and Sanders et al. (8) showed significantly better results.

View this table:
  • View inline
  • View popup
TABLE 4.

Other published evaluations of the ID-GNB card and Vitek 2 instrument

Table 5 shows a comparison of the results obtained when 454 of the same strains listed in Table 1 were tested with the Vitek GNI+ card. Table 5 lists those strains that were correctly identified, unidentified, or identified in error. The 25 strains in the tests with the ID-GNB card and the 8 strains in the tests with the GNI+ card for which there was a low probability of correct identification are not listed in Table 5. Even though the error rate was higher (4.6%) with the GNI+ card, only 1.7% of the identifications had low-probability confidence levels, whereas with the ID-GNB card, 5.5% of the identifications had low-probability confidence levels. Thus, there is no significant difference in the abilities of these two cards to identify these strains accurately (Yates' corrected P value, >0.05).

View this table:
  • View inline
  • View popup
TABLE 5.

Comparison of levels of accuracy of identification between ID-GNB and GNI+ cardsa

The question of the relative acceptable level of accuracy when a “system” approach is used for identification is often posed. This is a decision that must be made by each laboratory after it takes into consideration many variables. The two most prominent of these variables are the source of the specimen and whether the susceptibility pattern matches the identification of the organism. For example, an identification of Pantoea agglomerans from urine might not merit the same amount of concern that it would if it was isolated from blood or spinal fluid. Some laboratories are not willing to accept an answer that has less than an 85% probability of being accurate; others want an answer that is at least 90% accurate. Another consideration is whether the laboratory is able or willing in terms of time and money to perform the additional testing needed.

The hands-off approach to the Vitek 2 instrument with the Smart Carrier station is a major improvement of the Vitek instrument. Having demonstrated an overall accuracy above 90%, testing with the ID-GNB card presents an acceptable method for the identification of the most commonly isolated members of the family Enterobacteriaceae and nonenteric gram-negative bacilli.

FOOTNOTES

    • Received 9 August 2002.
    • Returned for modification 14 November 2002.
    • Accepted 19 February 2003.
  • American Society for Microbiology

REFERENCES

  1. ↵
    Edwards, P. R., and W. H. Ewing. 1972. Identification of Enterobacteriaceae, 3rd ed. Burgess Publishing Co., Minneapolis, Minn.
  2. ↵
    Farmer, J. J., III, M. A. Asbury, F. W. Hickman, D. J. Brenner, and the Enterobacteriaceae Study Group. 1980. Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int. J. Syst. Bacteriol. 30:569-584.
    OpenUrlCrossRef
  3. ↵
    Funke, G., D. Monnet, C. deBernardis, A. von Graevenitz, and J. Freney. 1998. Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J. Clin. Microbiol. 36:1948-1952.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Hickman, F. W., and J. J. Farmer III. 1978. Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing. Am. J. Med. Technol. 44:1149-1150.
    OpenUrlPubMedWeb of Science
  5. ↵
    Jossart, M. F., and R. J. Courcol. 1999. Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur. J. Clin. Microbiol. Infect. Dis. 18:902-907.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Joyanes, P., M. del Carmen Conejo, L. Martinez-Martinez, and E. J. Perea. 2001. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J. Clin. Microbiol. 39:3247-3253.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Ling, T. K. W., P. C. Tam, Z. K. Liu, and A. F. B. Cheng. 2001. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J. Clin. Microbiol. 39:2964-2966.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Sanders, C. C., M. Peyret, E. S. Moland, S. J. Cavalieri, C. Shubert, K. S. Thomson, J. M. Boeufgras, and W. E. Sanders, Jr. 2001. Potential impact of the VITEK 2 system and the advanced expert system on the clinical laboratory of a university-based hospital. J. Clin. Microbiol. 39:2379-2385.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Schreckenberger, P. C. 2000. Practical approach to the identification of glucose-nonfermenting gram-negative bacilli. University of Chicago, Chicago, Ill.
  10. ↵
    Weyant, R. S., C. W. Moss, R. E. Weaver, D. G. Hollis, J. G. Jordan, E. C. Cook, and M. I. Daneshvar. 1995. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of the Vitek 2 ID-GNB Assay for Identification of Members of the Family Enterobacteriaceae and Other Nonenteric Gram-Negative Bacilli and Comparison with the Vitek GNI+ Card
Caroline M. O'Hara, J. Michael Miller
Journal of Clinical Microbiology May 2003, 41 (5) 2096-2101; DOI: 10.1128/JCM.41.5.2096-2101.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Vitek 2 ID-GNB Assay for Identification of Members of the Family Enterobacteriaceae and Other Nonenteric Gram-Negative Bacilli and Comparison with the Vitek GNI+ Card
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
Share
Evaluation of the Vitek 2 ID-GNB Assay for Identification of Members of the Family Enterobacteriaceae and Other Nonenteric Gram-Negative Bacilli and Comparison with the Vitek GNI+ Card
Caroline M. O'Hara, J. Michael Miller
Journal of Clinical Microbiology May 2003, 41 (5) 2096-2101; DOI: 10.1128/JCM.41.5.2096-2101.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS AND DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X